208 related articles for article (PubMed ID: 11237835)
61. Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice.
Liu L; Wakamatsu K; Ito S; Williamson PR
Infect Immun; 1999 Jan; 67(1):108-12. PubMed ID: 9864203
[TBL] [Abstract][Full Text] [Related]
62. In vitro photodynamic inactivation of Cryptococcus neoformans melanized cells with chloroaluminum phthalocyanine nanoemulsion.
Rodrigues GB; Primo FL; Tedesco AC; Braga GU
Photochem Photobiol; 2012; 88(2):440-7. PubMed ID: 22145636
[TBL] [Abstract][Full Text] [Related]
63. Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects.
Almeida F; Wolf JM; da Silva TA; DeLeon-Rodriguez CM; Rezende CP; Pessoni AM; Fernandes FF; Silva-Rocha R; Martinez R; Rodrigues ML; Roque-Barreira MC; Casadevall A
Nat Commun; 2017 Dec; 8(1):1968. PubMed ID: 29213074
[TBL] [Abstract][Full Text] [Related]
64. Melanization of Cryptococcus neoformans reduces its susceptibility to the antimicrobial effects of silver nitrate.
García-Rivera J; Casadevall A
Med Mycol; 2001 Aug; 39(4):353-7. PubMed ID: 11556765
[TBL] [Abstract][Full Text] [Related]
65. Ketoconazole therapy of murine cryptococcal meningitis.
Craven PC; Graybill JR; Jorgensen JH
Am Rev Respir Dis; 1982 Jun; 125(6):696-700. PubMed ID: 6283969
[TBL] [Abstract][Full Text] [Related]
66. Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection.
Bryan RA; Jiang Z; Howell RC; Morgenstern A; Bruchertseifer F; Casadevall A; Dadachova E
J Infect Dis; 2010 Aug; 202(4):633-7. PubMed ID: 20594103
[TBL] [Abstract][Full Text] [Related]
67. The effects of glyphosate on the in vitro linear growth of selected microfungi from a boreal forest soil.
Tanney JB; Hutchison LJ
Can J Microbiol; 2010 Feb; 56(2):138-44. PubMed ID: 20237575
[TBL] [Abstract][Full Text] [Related]
68. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans.
Wang Y; Aisen P; Casadevall A
Infect Immun; 1996 Jul; 64(7):2420-4. PubMed ID: 8698461
[TBL] [Abstract][Full Text] [Related]
69. Vesicle-associated melanization in Cryptococcus neoformans.
Eisenman HC; Frases S; Nicola AM; Rodrigues ML; Casadevall A
Microbiology (Reading); 2009 Dec; 155(Pt 12):3860-3867. PubMed ID: 19729402
[TBL] [Abstract][Full Text] [Related]
70. Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa.
Nosanchuk JD; Casadevall A
Microbiology (Reading); 2003 Jul; 149(Pt 7):1945-1951. PubMed ID: 12855745
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of laccases and melanization in clinical and environmental Cryptococcus neoformans samples by non-denaturing PAGE.
Pereira CB; Bueno FL; Dias ALT; Brigagão MRPL; Paula CR; Siqueira AM
J Med Microbiol; 2009 May; 58(Pt 5):563-566. PubMed ID: 19369516
[TBL] [Abstract][Full Text] [Related]
72. Measuring Laccase Activity and Melanin Production in Cryptococcus neoformans.
Albuquerque P; de Sousa HR; de Oliveira Frazão S; do Nascimento Miranda LV; Paes HC; Pereira IS; Nicola AM
Methods Mol Biol; 2024; 2775():257-268. PubMed ID: 38758323
[TBL] [Abstract][Full Text] [Related]
73. Treatment of murine cryptococcosis with cyclosporin-A in normal and athymic mice.
Mody CH; Toews GB; Lipscomb MF
Am Rev Respir Dis; 1989 Jan; 139(1):8-13. PubMed ID: 2643377
[TBL] [Abstract][Full Text] [Related]
74. Targeted Theranostic of Cryptococcal Encephalitis by a Novel Polypyridyl Ruthenium Complex.
Wang Q; Fu C; Zhao Z; Fu A
Mol Pharm; 2020 Jan; 17(1):145-154. PubMed ID: 31800255
[No Abstract] [Full Text] [Related]
75. Cryptococcus neoformans can utilize the bacterial melanin precursor homogentisic acid for fungal melanogenesis.
Frases S; Salazar A; Dadachova E; Casadevall A
Appl Environ Microbiol; 2007 Jan; 73(2):615-21. PubMed ID: 17098915
[TBL] [Abstract][Full Text] [Related]
76. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents.
Rosas AL; Nosanchuk JD; Feldmesser M; Cox GM; McDade HC; Casadevall A
Infect Immun; 2000 May; 68(5):2845-53. PubMed ID: 10768981
[TBL] [Abstract][Full Text] [Related]
77. Isolation and characterization of senescent Cryptococcus neoformans and implications for phenotypic switching and pathogenesis in chronic cryptococcosis.
Jain N; Cook E; Xess I; Hasan F; Fries D; Fries BC
Eukaryot Cell; 2009 Jun; 8(6):858-66. PubMed ID: 19411622
[TBL] [Abstract][Full Text] [Related]
78. Transcriptomic analysis reveals the relationship of melanization to growth and resistance to gamma radiation in Cryptococcus neoformans.
Schultzhaus Z; Chen A; Kim S; Shuryak I; Chang M; Wang Z
Environ Microbiol; 2019 Aug; 21(8):2613-2628. PubMed ID: 30724440
[TBL] [Abstract][Full Text] [Related]
79. Identification of a major IP5 kinase in Cryptococcus neoformans confirms that PP-IP5/IP7, not IP6, is essential for virulence.
Li C; Lev S; Saiardi A; Desmarini D; Sorrell TC; Djordjevic JT
Sci Rep; 2016 Apr; 6():23927. PubMed ID: 27033523
[TBL] [Abstract][Full Text] [Related]
80.
Beattie SR; Jezewski AJ; Ristow LC; Wellington M; Krysan DJ
mSphere; 2022 Jun; 7(3):e0016322. PubMed ID: 35506343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
